XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Ş

How I Manage Febrile Neutropenia in Patients With Cancer

By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING Şiran Keske
By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING Şiran Keske
58 views
February 21, 2024

Chapters

Epidemiology & Antibiotic Resistance in Febrile Neutropenia

00:00

Classifying Febrile Neutropenia & Risk Assessments

01:18

Pathogens & Management Pathways in Cancer Patients

04:11

Challenges in Antimicrobial Stewardship Programs

07:51

Multidisciplinary Approach & Importance of Rapid Tests

11:39

Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

17:01
Hematology Content

Q&A: Panel Discussion of a Treatment Option for ITP

Feat. T. Gernsheimer, J. Bussel, L. Tolba

Recommended

AUTOPLAY
11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.3K views

·

8 months ago
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.2K views

·

4 months ago
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views

·

9 months ago
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.2K views

·

6 months ago
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

568 views

·

2 months ago
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

695 views

·

3 months ago
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

811 views

·

4 months ago
17:51

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Indy Hematology Review

H. Erba

882 views

·

6 months ago
16:42

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

H. Hashmi

1.6K views

·

9 months ago
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

543 views

·

4 months ago
35:12

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

315 views

·

3 months ago
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

610 views

·

4 months ago
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

620 views

·

4 months ago
13:07

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Moffitt Cancer Center

J. Chavez

816 views

·

8 months ago
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

123 views

·

2 months ago
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

484 views

·

4 months ago
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

724 views

·

6 months ago
28:20

Managing Newly Diagnosed MM in 2024

Indy Hematology Review

S. Usmani

681 views

·

6 months ago
17:46

ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies on a …

Insights from 2023 ASH Annual Meeting

A. Jakubowiak

1.4K views

·

10 months ago